中国全科医学2025，Vol.28Issue(17)：2070-2074,5.DOI:10.12114/j.issn.1007-9572.2024.0323
2024年V1/V2版《NCCN直肠癌临床实践指南》更新要点解读
Interpretation of Updated NCCN Clinical Guidelines for Rectal Cancer(2024.V1/V2)
摘要
Abstract
The incidence of colorectal cancer ranks second among cancers in China and colorectal cancer is also one of the most common malignant tumors in the digestive system.With the development of medical research and technology,the diagnostic and therapeutic strategies of colorectal cancer are continuously evolving.The National Comprehensive Cancer Network(NCCN)is closely following the forefront and released the 2024 V1/V2 versions of the NCCN Clinical Practice Guidelines for Rectal Cancer on January 29 and April 4,2024 respectively.The two revisions of the guidelines mainly focus on the latest research progress in molecular detection,immunotherapy,targeted therapy,neoadjuvant therapy and disease surveillance.This article analyzed the key updates of the 2024 V1/V2 NCCN guidelines,aiming to provide a more accurate reference for clinical rectal cancer diagnosis and treatment practice.关键词
直肠肿瘤/基因突变检测/治疗策略/监测/美国国家综合癌症网络/指南解读Key words
Rectal neoplasms/Mutation testing/Treatment strategy/Surveillance/NCCN/Guidelines interpretation分类
临床医学引用本文复制引用
曹沁涵,卓肖,夏雨菡,车杨曦,陈敏..2024年V1/V2版《NCCN直肠癌临床实践指南》更新要点解读[J].中国全科医学,2025,28(17):2070-2074,5.基金项目
国家自然科学基金面上项目(82274529) （82274529）
科研能力提升"百人计划"(20-B05) （20-B05）
